Ann Liver Transplant.  2023 Nov;3(2):69-72. 10.52604/alt.23.0017.

Liver transplantation for giant hepatic hemangioma: A collective review

• Park CS
• Chung YK

• KMID: 2560925
• DOI: http://doi.org/10.52604/alt.23.0017

Abstract

Giant hepatic hemangiomas (HHs) have been often considered benign, but their huge size and potential complications can make them far from benign in their impact on the lives. Amid the myriad of treatment options available, liver transplantation (LT) has been performed for giant HHs that have serious clinical manifestations. This study reviewed the role of LT as an indication for giant HH. The literature was searched using search terms as follows in all possible combinations: “liver hemangioma”, “giant hemangioma”, “liver transplantation”, and “Kasabach-Merritt syndrome”. A total of 18 studies were finally included in the present analysis, which recruited 19 patients. The mean age of patients was 39.9±8.6 years. The most common reported symptoms were abdominal distention, respiratory distress, upper abdominal pain, excessive bleeding, and coagulopathy. Preoperative laboratory tests showed abnormal liver function in all patients. Nine patients were diagnosed with Kasabach-Merritt syndrome. Fourteen patients received deceased donor LT whereas the remaining 5 patients underwent living donor LT. No intraoperative or postoperative 90-day mortality following LT was documented. All abnormal blood parameters returned to normal within few days postoperatively in all patients. All patients were alive at the time of their documentation. In conclusion, LT is a safe and effective treatment option in the management of symptomatic or complicated giant HH in selected patients.

Keyword

Hemangioma; Liver transplantation; Abdominal distension; Kasabach-Merritt syndrome; Coagulopathy

Reference

1. Prodromidou A, Machairas N, Garoufalia Z, Kostakis ID, Tsaparas P, Paspala A, et al. 2019; Liver transplantation for giant hepatic hemangioma: a systematic review. Transplant Proc. 51:440–442. DOI: 10.1016/j.transproceed.2019.01.018. PMID: 30879561.

2. Bajenaru N, Balaban V, Săvulescu F, Campeanu I, Patrascu T. 2015; Hepatic hemangioma -review-. J Med Life. 8(Spec Issue):4–11.

3. Zhao Y, Li XP, Hu YY, Jiang JC, Zhao LJ. 2022; Liver transplantation for giant hemangioma of the liver: a case report and review of the literature. Front Med (Lausanne). 9:985181. DOI: 10.3389/fmed.2022.985181. PMID: 36186795. PMCID: PMC9523786.

4. Zhao Y, Legan CE. 2022; Liver transplantation for giant hemangioma complicated by Kasabach-Merritt syndrome: a case report and literature review. Am J Case Rep. 23:e936042. DOI: 10.12659/AJCR.936042.

5. Eghlimi H, Arasteh P, Azade N. 2020; Orthotopic liver transplantation for Management of a Giant Liver Hemangioma: a case report and review of literature. BMC Surg. 20:142. DOI: 10.1186/s12893-020-00801-z. PMID: 32600292. PMCID: PMC7324977.

6. Lee JH, Yoon CJ, Kim YH, Han HS, Cho JY, Kim H, et al. 2018; Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report. Clin Mol Hepatol. 24:163–168. DOI: 10.3350/cmh.2017.0002. PMID: 28719965. PMCID: PMC6038937.

7. Lange UG, Bucher JN, Schoenberg MB, Benzing C, Schmelzle M, Gradistanac T, et al. 2015; Orthotopic liver transplantation for giant liver haemangioma: a case report. World J Transplant. 5:354–359. DOI: 10.5500/wjt.v5.i4.354. PMID: 26722664. PMCID: PMC4689947.

8. Yildiz S, Kantarci M, Kizrak Y. 2014; Cadaveric liver transplantation for a giant mass. Gastroenterology. 146:e10–e11. DOI: 10.1053/j.gastro.2013.08.001. PMID: 24269562.

9. Zhong L, Men TY, Yang GD, Gu Y, Chen G, Xing TH, et al. 2014; Case report: living donor liver transplantation for giant hepatic hemangioma using a right lobe graft without the middle hepatic vein. World J Surg Oncol. 12:83. DOI: 10.1186/1477-7819-12-83. PMID: 24708716. PMCID: PMC4016776.

10. Unal E, Francis F, Aquino A, Xu R, Morgan G, Teperman L. 2011; Liver transplant for mixed capillary-cavernous hemangioma masquerading as hepatocellular carcinoma in a patient with hepatocellular carcinoma. Exp Clin Transplant. 9:344–348.

11. Vagefi PA, Klein I, Gelb B, Hameed B, Moff SL, Simko JP, et al. 2011; Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review. J Gastrointest Surg. 15:209–214. DOI: 10.1007/s11605-010-1248-1. PMID: 20549381. PMCID: PMC3023038.

12. Aseni P, Lauterio A, Slim AO, Giacomoni A, Lamperti L, De Carlis L. 2010; Life-saving super-urgent liver transplantation with replacement of retrohepatic vena cava by Dacron graft. HPB Surg. 2010:828326. DOI: 10.1155/2010/828326. PMID: 20811479. PMCID: PMC2926580.

13. Meguro M, Soejima Y, Taketomi A, Ikegami T, Yamashita Y, Harada N, et al. 2008; Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case. Surg Today. 38:463–468. DOI: 10.1007/s00595-007-3623-4. PMID: 18560973.

14. Ferraz AA, Sette MJ, Maia M, Lopes EP, Godoy MM, Petribú AT, et al. 2004; Liver transplant for the treatment of giant hepatic hemangioma. Liver Transpl. 10:1436–1437. DOI: 10.1002/lt.20250. PMID: 15497149.

15. Kumashiro Y, Kasahara M, Nomoto K, Kawai M, Sasaki K, Kiuchi T, et al. 2002; Living donor liver transplantation for giant hepatic hemangioma with Kasabach-Merritt syndrome with a posterior segment graft. Liver Transpl. 8:721–724. DOI: 10.1053/jlts.2002.33689. PMID: 12149767.

16. Keegan MT, Kamath GS, Vasdev GM, Findlay JY, Gores GJ, Steers JL, et al. 2001; Liver transplantation for massive hepatic haemangiomatosis causing restrictive lung disease. Br J Anaesth. 86:431–434. DOI: 10.1093/bja/86.3.431. PMID: 11573537.

17. Longeville JH, de la Hall P, Dolan P, Holt AW, Lillie PE, Williams JA, et al. 1997; Treatment of a giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant a case report. HPB Surg. 10:159–162. DOI: 10.1155/1997/10136. PMID: 9174860. PMCID: PMC2423854.

18. Russo MW, Johnson MW, Fair JH, Brown RS Jr. 1997; Orthotopic liver transplantation for giant hepatic hemangioma. Am J Gastroenterol. 92:1940–1941.

19. Chui AK, Vass J, McCaughan GW, Sheil AG. 1996; Giant cavernous haemangioma: a rare indication for liver transplantation. Aust N Z J Surg. 66:122–124. DOI: 10.1111/j.1445-2197.1996.tb01132.x. PMID: 8602810.

20. Klompmaker IJ, Sloof MJ, van der Meer J, de Jong GM, de Bruijn KM, Bams JL. 1989; Orthotopic liver transplantation in a patient with a giant cavernous hemangioma of the liver and Kasabach-Merritt syndrome. Transplantation. 48:149–151. DOI: 10.1097/00007890-198907000-00035. PMID: 2501918.

21. Liu X, Yang Z, Tan H, Xu L, Liu L, Huang J, et al. 2018; Patient age affects the growth of liver haemangioma. HPB (Oxford). 20:64–68. DOI: 10.1016/j.hpb.2017.08.021. PMID: 28927653.

22. Moctezuma-Velázquez C, López-Arce G, Martínez-Rodríguez LA, Escalona-Huerta C, Chapa-Ibargüengoitia M, Torre A. 2014; Giant hepatic hemangioma versus conventional hepatic hemangioma: clinical findings, risk factors, and management. Rev Gastroenterol Mex. 79:229–237. DOI: 10.1016/j.rgmxen.2014.12.004. PMID: 25438870.

23. Aziz H, Brown ZJ, Baghdadi A, Kamel IR, Pawlik TM. 2022; A comprehensive review of hepatic hemangioma management. J Gastrointest Surg. 26:1998–2007. DOI: 10.1007/s11605-022-05382-1. PMID: 35705835.

24. Lee JM. 2022; Changes in the deceased-donor trend in Korea: establishment of regional trauma centers and KODA. J Clin Med. 11:1239. DOI: 10.3390/jcm11051239. PMID: 35268330. PMCID: PMC8911019.